Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena Conti

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|February 26, 2017
Patients' preferences in transplantation from marginal donors: results of a discrete choice experimentSara Kamran, Filomena Conti, Marie-Pascale Pomey, et al.
Clinics and Research in Hepatology and Gastroenterology|November 28, 2017
Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacityKhaldoun Ghazal, Fabien Stenard, Géraldine Dahlqvist, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 5, 2002
Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypesPierre Cattan, Thierry Berney, Filomena Conti, et al.
Clinics and Research in Hepatology and Gastroenterology|November 26, 2018
Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent resultsAstrid Schielke, Olivier Scatton, Pierre-Yves Boelle, et al.
World Journal of Surgery|August 2, 2012
Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resectionHadrien Tranchart, Mircea Chirica, Ailton Sepulveda, et al.
Clinics and Research in Hepatology and Gastroenterology|May 9, 2016
Two-stage liver transplantation using auxiliary laparoscopically harvested grafts in adults: Emphasizing the concept of "hypersmall graft nursing"Olivier Scatton, François Cauchy, Filomena Conti, et al.
Cellular & Molecular Immunology|June 11, 2025
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapyDeniz Seyhan, Manon Allaire, Yaojie Fu, et al.
Clinical Immunology (Orlando, Fla.)|November 19, 2024
HLA evolutionary divergence effect on bacterial infection risk in cirrhotic liver transplant candidatesAlessandra Mazzola, Clémentine Roger, Romain Lhotte, et al.
World Journal of Gastroenterology|December 14, 2020
COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case reportAnna Sessa, Alessandra Mazzola, Chetana Lim, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2023
Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in FranceAudrey Coilly, Carine Jasseron, Camille Legeai, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Transplant International : Official Journal of the European Society for Organ Transplantation|February 26, 2017
Patients' preferences in transplantation from marginal donors: results of a discrete choice experimentSara Kamran, Filomena Conti, Marie-Pascale Pomey, et al.
Clinics and Research in Hepatology and Gastroenterology|November 28, 2017
Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacityKhaldoun Ghazal, Fabien Stenard, Géraldine Dahlqvist, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 5, 2002
Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypesPierre Cattan, Thierry Berney, Filomena Conti, et al.
Clinics and Research in Hepatology and Gastroenterology|November 26, 2018
Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent resultsAstrid Schielke, Olivier Scatton, Pierre-Yves Boelle, et al.
World Journal of Surgery|August 2, 2012
Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resectionHadrien Tranchart, Mircea Chirica, Ailton Sepulveda, et al.
Clinics and Research in Hepatology and Gastroenterology|May 9, 2016
Two-stage liver transplantation using auxiliary laparoscopically harvested grafts in adults: Emphasizing the concept of "hypersmall graft nursing"Olivier Scatton, François Cauchy, Filomena Conti, et al.
Cellular & Molecular Immunology|June 11, 2025
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapyDeniz Seyhan, Manon Allaire, Yaojie Fu, et al.
Clinical Immunology (Orlando, Fla.)|November 19, 2024
HLA evolutionary divergence effect on bacterial infection risk in cirrhotic liver transplant candidatesAlessandra Mazzola, Clémentine Roger, Romain Lhotte, et al.
World Journal of Gastroenterology|December 14, 2020
COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case reportAnna Sessa, Alessandra Mazzola, Chetana Lim, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2023
Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in FranceAudrey Coilly, Carine Jasseron, Camille Legeai, et al.
Pageof 13